ALIDYA

Alidya™ is the first injectable medical
device specifically indicated for the
prevention and treatment of gynoid
lipodystrophy (cellulite).
Originating from studies conducted
by Prof. Pasquale Motolese, who
identified the deposit of
extracellular toxic metals secondary.
The main action of Alidya™ is to
solubilize and remove these
extracellular toxic elements.
It also restores the normal
homeostasis of the cell, which
clinically produces the visible
effect of improvement of the
cellulite in the affected area, and
prevents further progression